Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-14

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing safety and efficacy of efalizumab in adults with moderate-to-severe plaque psoriasis with scalp involvement; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raptiva (efalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2011-02-14